Jump to content

FDA Seeks Patient Insight: Call for Applications for the Patient Engagement Collaborative | FDA

Recommended Posts


Today, the FDA announced the call for applications for the next cohort of the Patient Engagement Collaborative (PEC). The PEC, established in 2018 in collaboration with the Clinical Trials Transformation InitiativeExternal Link Disclaimer (CTTI), is a group of patient organizations and individual representatives who discuss ways to enhance patient engagement. CTTI and the FDA collaborate to involve representatives with a variety of perspectives including patients, caregivers and representatives from diverse patient organizations. The PEC is run by the FDA’s Patient Affairs staff, which is dedicated to providing an inviting, welcoming and meaningful experience for patient communities to engage with the FDA.

Representatives from the patient community who participate in the PEC include:

Patients who have personal disease experience.

Caregivers who have personal experience supporting someone with a health condition (e.g., a parent, child, partner, family member or friend).

Representatives from patient groups who have direct or indirect disease experience.

The PEC discusses topics such as:

Creating new ways to collaborate with patient communities.

Making patient engagement more systematic.

Improving transparency through education and outreach.

Enhancing communication between the FDA and patient communities.

Link to comment
Share on other sites

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...